An Investigator-Initiated Phase I Study To Assess The Safety And Tolerability Of Ex Vivo Next-Generation Neoantigen-Selected Tumor-Infiltrating Lymphocyte (Til) Therapy In Advanced Immune Checkpoint Blockade (Icb) Resistant Solid Tumors (Nextgentil-Act)
Tumor-Infiltrating Lymphocyte
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Investigator-Initiated Phase I Study To Assess The Safety And Tolerability Of Ex Vivo Next-Generation Neoantigen-Selected Tumor-Infiltrating Lymphocyte (Til) Therapy In Advanced Immune Checkpoint Blockade (Icb) Resistant Solid Tumors (Nextgentil-Act) ### Output: Tumor-Infiltrating Lymphocyte